mediri GmbH Information

What drives us is the ambition to offer state of the art medical imaging solutions which help to make the society advance. Clinical trials are the essence of evidence-based medicine, and therefore one core element to tackle emergent societal challenges like dementia, stroke and cancer. Artificial intelligence (AI) is the future in patient-individual diagnosis support. By establishing cost-effective AI solutions, patients will benefit most from the ongoing advances in machine learning based research. Since the foundation of mediri in 2004, we accompany our customers to improve services and data quality in clinical trials and medical image analysis software: •Our browser-based solution “mTRIAL” helps to easily manage imaging in clinical trials. mTRIAL connects sites, sponsors and central readers in clinical trials. •Our automated quality assessment software “AQUA” gives instant feedback on image quality during the image upload process to ensure high data quality in clinical trials. •We offer central read solutions, browser-based and with MacBook support. •We act as imaging CRO and core lab: Our services include central read services, radiology site management and image management in several national and international multi-center trials. •Our research activities are focused on AI solutions. We participate in funded research projects with renowned academic partners to make deep learning a reality in diagnosis support. An example is the automatic segmentation of anatomic structures and lesions in Multiple Sclerosis.